Company / FCF Margin
Alaunos Therapeutics, Inc. FCF Margin History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-49710.0%
FY2025
5-year range
-606780.0% / -1007.8%
FY2021-FY2025
Trend
+91.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 8 years, ranging from -606780.0% in FY2024 to -348.5% in FY2019.
Based on SEC 10-K filings.
-49710.0% in FY2025 with a 5-year CAGR of -15521.0%.
Declined from -1007.8% to -49710.0% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -33430.8pp
- 5-Year Change
- -15521.0pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 91.8% year-over-year.
- Peak fcf margin was recorded in FY2019.
- Lowest fcf margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -49710.0% | +91.8% |
| FY2024 | -606780.0% | -60108.4% |
| FY2023 | -1007.8% | +93.8% |
| FY2022 | -16279.2% | - |
| FY2021 | - | - |
| FY2020 | -34189.0% | -9711.2% |
| FY2019 | -348.5% | +5.9% |
| FY2018 | -370.3% | - |
| FY2013 | - | - |
| FY2012 | -2980.5% | -61.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026